Pharmafile Logo
Pharmafocus logo
Advanced Search

Nephrology

Showing 15 posts of 22 posts found.

Evotec and Bayer announce new kidney disease study

December 11, 2025
Research and Development Bayer, Evotec, Nephrology

Evotec and Bayer have announced the initiation of a phase 2 clinical study in kidney disease, stemming from their previous …

News
surgery

SphingoTec’s PenKid leads the way in early detection of delayed graft function after kidney transplant

July 1, 2025
Medical Communications, Research and Development Nephrology, PenKid, SphingoTec, biomarker, clinical trial, delayed graft function, kidney replacement therapy, kidney transplant, serum creatinine

SphingoTec has announced new findings validating the clinical utility of its kidney biomarker proenkephalin A 119-159 (PenKid) in assessing graft …

News

Opterion Health strengthens board with appointments of Rice Powell and Mark Hahn

June 25, 2025
Research and Development CEO, Nephrology, Opterion Health, board of directors, cfo, chronic kidney disease, dialysis solution

Swiss life sciences company Opterion Health has appointed two senior industry figures to its board of directors: Rice Powell, former …

Appointment

Takeda presents positive results from trial of chronic kidney disease treatment

June 10, 2025
Research and Development European Renal Association, Immunology, Nephrology, Takeda, autoimmune disease, immunoglobulin A nephropathy (IgAN), kidney disease

Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat patients with primary immunoglobulin A …

News

NIPRO introduces LiniXia water treatment system for dialysis clinics

June 4, 2025
Research and Development European Renal Association (ERA) Congress, LiniXia, LiniXia PRO, NIPRO, Nephrology, dialysis clinics, water treatment

Japan-based biopharma, NIPRO, has launched LiniXia, a new reverse osmosis (RO) water treatment system for haemodialysis. It was unveiled at …

News

NICE recommends treatment for chronic kidney disease, IgA nephropathy

May 23, 2025
Market & Product Development, Medical Communications, Research and Development IgA nephropathy, National Institute for Health and Care Excellence, Nephrology, kidney disease

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending CSL Vifor’s FILSPARI (sparsentan) for …

News
europe-1395916_640

EU approval granted for rare kidney disease treatment

April 29, 2025
Market Access, Research and Development, Sales and Marketing CSL Vifor, EU, Nephrology, Travere Therapeutics, kidney disease, nephrology

The EU has granted marketing authorisation (MA) for Filspari – CSL Vifor and Travere Therapeutics’ therapy for primary IgA nephropathy …

News

Kidney Research UK backs digital innovation to support 15 million patients with long-term conditions

April 22, 2025
Medical Education, Patient Awareness Programmes, Public Relations Cognitant Group, Kidney Research UK, Nephrology, chronic kidney disease (CKD)

Kidney Research UK has announced an ambitious investment in the patient engagement platform Healthinote, developed by Cognitant Group, in a …

News

VALIANT phase 3 trial results highlight potential treatment for rare kidney diseases

October 25, 2024
Nephrology, Rare Diseases, rare kidney disease, trial

SOBI and Apellis Pharmaceuticals have announced the results from the VALIANT trial, which highlight that systemic pegcetacoplan treatment could benefit …

News

China’s NMPA accepts Everest Medicines’ Nefecon supplementary application

July 18, 2024
Medical Communications China, Everest Medicines, NMPA, Nephrology

Everest Medicines has announced that China’s National Medical Products Administration (NMPA) has accepted the submission of a supplemental New Drug …

News

Renalys Pharma closes ¥6bn series A financing for kidney disease treatments in Asia

July 17, 2024
Business Services Financing, Nephrology, kidney disease, renalys Pharma

Renalys Pharma has announced that it has completed ¥6bn series A financing, which was led by Catalys Pacific and SR …

News

Novartis shares new data about Fabhalta for IgAN treatment

April 16, 2024
Research and Development Fabhalta, IgAN, Nephrology, Novartis, nephropathy

Novartis has announced new results from a pre-specified interim analysis of its phase 3 APPLAUSE-IgAN trial of Fabhalta (iptacopan), an …

News

Vertex to acquire Alpine Immune Sciences for $4.9bn

April 11, 2024
Business Services Alpine Immune Sciences, Nephrology, Vertex pharmaceuticals, acquisition, nephropathy

Vertex Pharmaceuticals and Alpine Immune Sciences have announced that they have entered into a definitive agreement under which Vertex will …

News

Fresenius Medical Care gains FDA 501(k) clearance for haemodialysis system

February 9, 2024
Medical Communications 501(k), FDA, Fresenius Medical Care, Nephrology, dialysis

Fresenius Medical Care has announced that it has received US Food and Drug Administration (FDA) 501(k) clearance for its 5008X …

News

Calliditas Therapeutics gains FDA approval of Tarpeyo

December 22, 2023
Medical Communications Calliditas, FDA, Nephrology, kidneys

Calliditas Therapeutics has announced that the US Food and Drug Administration (FDA) has approved Tarpeyo (budesonide) delayed release capsules to …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025